The safety of gliptins : updated data in 2018
Year: 2018
Type: review
Source: Expert Opinion on Drug Safety
Author: André Jacques Scheen
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: DPP-4 inhibitors, drug safety, type 2 diabetes, alogliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin, hypoglycemia, pancreatitis, pancreatic cancer, cardiovascular events, heart failure hospitalization, bone fractures, joint pain, renal dysfunction, liver disease, elderly patients, pharmacovigilance
Open Access status: closed
OpenAlex ID: W2793303845
